S. Miyakis, M. D. Lockshin, T. Atsumi, D. W. Branch, R. L. Brey et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost JTH, vol.4, p.16420554, 2006.

C. Ló-pez-pedrera, P. Buendía, M. J. Cuadrado, E. Siendones, M. A. Aguirre et al., Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway, Arthritis Rheum, vol.54, p.16385547, 2006.

A. V. Kinev and R. Roubey, Tissue factor in the antiphospholipid syndrome, Lupus, vol.17, p.18827061, 2008.

K. Ahmed, J. L. Vianna, M. A. Khamashta, and G. R. Hughes, IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome, Clin Exp Rheumatol, vol.10, p.1458705, 1992.

S. S. Pierangeli, R. G. Espinola, X. Liu, and E. N. Harris, Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin, Circ Res, vol.88, p.11157679, 2001.

G. Kaplanski, P. Cacoub, C. Farnarier, V. Marin, R. Gré-goire et al., Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis, Arthritis Rheum, vol.43, pp.55-64, 2000.

Y. Benhamou, J. Bellien, G. Armengol, E. Brakenhielm, S. Adriouch et al., Role of toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome, Arthritis Rheumatol, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02296566

M. Charakida, C. Besler, J. R. Batuca, S. Sangle, S. Marques et al., Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome, JAMA J Am Med Assoc, vol.302, pp.1210-1217, 2009.

F. Mercanoglu, D. Erdogan, H. Oflaz, R. Kücü-kkaya, F. Selcukbiricik et al., Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome, Int J Clin Pract, vol.58, p.15605661, 2004.

D. Tanne, A. Katzav, O. Beilin, N. C. Grigoriadis, M. Blank et al., Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome, Neurobiol Dis, vol.30, p.18308578, 2008.

Y. Benhamou, S. Miranda, G. Armengol, N. Harouki, L. Drouot et al., Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: role of reduced oxidative stress, Vascul Pharmacol, vol.71, p.25869505, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02296630

A. Schmidt-tanguy, J. Voswinkel, D. Henrion, J. F. Subra, L. Loufrani et al., Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients, J Thromb Haemost JTH, vol.11, p.23902281, 2013.

R. G. Espinola, S. S. Pierangeli, A. E. Gharavi, E. N. Harris, and A. E. Ghara, Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies, Thromb Haemost, vol.87, p.11916085, 2002.

J. H. Rand, X. Wu, A. S. Quinn, A. W. Ashton, P. P. Chen et al., Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug, Blood, vol.115, pp.2292-2299, 2010.

K. Schreiber, K. Breen, K. Parmar, J. H. Rand, X. Wu et al., The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies, Rheumatol Oxf Engl, vol.57, pp.120-124, 2018.

P. Billoir, S. Miranda, D. L. Richard, V. Benhamou, Y. Duchez et al., Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies, Thromb Res, vol.169, p.30031291, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02296609

S. Ramesh, C. N. Morrell, C. Tarango, G. D. Thomas, I. S. Yuhanna et al., Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via ?2GPI and apoER2, J Clin Invest, vol.121, p.21123944, 2011.

J. C. Reverter, D. Tàssies, J. Font, J. Monteagudo, G. Escolar et al., Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s, Arterioscler Thromb Vasc Biol, vol.16, p.8911269, 1996.

M. J. Cuadrado, C. López-pedrera, M. A. Khamashta, M. T. Camps, F. Tinahones et al., Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression, Arthritis Rheum, vol.40, pp.834-841, 1997.

P. M. Dobado-berrios, C. Ló-pez-pedrera, F. Velasco, M. A. Aguirre, A. Torres et al., Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome, Thromb Haemost, vol.82, p.10613637, 1999.

A. Kornberg, M. Blank, S. Kaufman, and Y. Shoenfeld, Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies, J Immunol Baltim Md, vol.153, pp.1328-1332, 1950.

O. Amengual, T. Atsumi, M. A. Khamashta, and G. R. Hughes, The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome, Thromb Haemost, vol.79, p.9493575, 1998.

J. C. Reverter, D. Tàssies, J. Font, M. A. Khamashta, K. Ichikawa et al., Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes, Arthritis Rheum, vol.41, pp.1420-1427, 1998.

H. Zhou, A. S. Wolberg, and R. Roubey, Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep, Blood, vol.104, pp.2353-2358, 2004.

S. S. Pierangeli, M. Colden-stanfield, X. Liu, J. H. Barker, G. L. Anderson et al., Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo, Circulation, vol.99, p.10209004, 1999.

N. Prinz, N. Clemens, A. Canisius, and K. J. Lackner, Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells. Lessons from the antiphospholipid syndrome, Thromb Haemost, vol.109, p.23328933, 2013.

H. C. Hemker, A. Dieri, R. , D. Smedt, E. Béguin et al., Thrombin generation, a function test of the haemostaticthrombotic system, Thromb Haemost, vol.96, p.17080210, 2006.

J. J. Van-veen, A. Gatt, and M. Makris, Thrombin generation testing in routine clinical practice: are we there yet?, Br J Haematol, vol.142, p.18564356, 2008.

I. Dienava-verdoold, M. G. Boon-spijker, P. G. De-groot, H. Brinkman, J. Voorberg et al., Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity, J Thromb Haemost JTH, vol.9, p.21255251, 2011.

V. Regnault, S. Béguin, D. Wahl, E. De-maistre, C. Hemker et al., Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants, Thromb Haemost, vol.89, p.12574797, 2003.

M. Efthymiou, A. S. Lawrie, I. Mackie, D. Arachchillage, P. J. Lane et al., Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome, Thromb Res, vol.135, p.25895847, 2015.

. Rikarni-null, R. Dharma, K. L. Tambunan, H. Isbagyo, B. E. Dewi et al., Prothrombotic Effect of Anti-beta-2 Glycoprotein-1 Antibodies on the Expression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells, Acta Medica Indones, vol.47, pp.31-37, 2015.

M. H. Edwards, S. Pierangeli, X. Liu, J. H. Barker, G. Anderson et al., Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice, Circulation, vol.96, p.9416907, 1997.

H. Cohen, B. J. Hunt, M. Efthymiou, D. Arachchillage, I. J. Mackie et al., Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial, Lancet Haematol, vol.3, p.27570089, 2016.

A. Sacharidou, K. L. Chambliss, V. Ulrich, J. E. Salmon, Y. Shen et al., Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium, Blood, vol.131, p.29500169, 2018.

R. Li, H. Lin, Y. Ye, Y. Xiao, S. Xu et al., Attenuation of antimalarial agent hydroxychloroquine on TNF-?-induced endothelial inflammation, Int Immunopharmacol, vol.63, p.30121047, 2018.

N. Müller-calleja, D. Manukyan, A. Canisius, D. Strand, and K. J. Lackner, Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase, Ann Rheum Dis, vol.76, p.27903507, 2017.

N. Müller-calleja, A. Hollerbach, F. Häuser, A. Canisius, C. Orning et al., Antiphospholipid antibodyinduced cellular responses depend on epitope specificity: implications for treatment of antiphospholipid syndrome, J Thromb Haemost, vol.15, p.29024318